🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Laut der Inhaltsstoffliste enthält das Produkt 2-(4-tert-Butylbenzyl)propionaldehyd (BMHCA), das in kosmetischen Produkten verboten ist. BMHCA kann das Fortpflanzungssystem schädigen, die Gesundheit des ungeborenen Kindes schädigen und Hautsensibilisierung verursachen. Darüber hinaus enthält das Produkt Hydroxyisohexyl-3-cyclohexencarboxaldehyd (HICC), das in kosmetischen Produkten verboten ist. HICC kann eine allergische Hautreaktion hervorrufen. Das Produkt entspricht nicht der Verordnung über kosmetische Produkte.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Ban on the marketing of the product and any accompanying measures
Date of entry into force
15/02/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): KWA KWA Eau de Perfume
Risk Description (original English): According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
Moreover, the product contains hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC), which is prohibited in cosmetic products. HICC may cause an allergic skin reaction.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.